IBI3014

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3014, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]